Crack-Down On Homeopathic Products Pushed By EU Science Advisory Council
This article was originally published in The Pink Sheet
European Academies Science Advisory Council urges “standardized, knowledge-based” regulatory framework for homeopathic products, similar to requirements for medicinal products in the EU. The umbrella organization representing 29 European scientific bodies says claims for the products are too often “implausible” and threaten consumer health.
You may also be interested in...
The National Health Service in England has drawn up a proposed list of “ineffective and dangerous” medicines that should not be routinely used in primary care, in a move to conserve resources and improve patient outcomes. They include products containing substances like fentanyl, tadalafil and trimipramine, as well as homeopathics and traditional herbal medicines.
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.
Legal experts note that J&J’s decision to end Johnson’s Baby Powder sales in the US and Canada closely followed a New Jersey federal court decision that largely denied the firm’s motions to bar testimony from plaintiff experts in multi-district talc litigation comprising around 16,000 cases.